期刊文献+

尿胞外体亮氨酸氨基肽酶及二肽基肽酶在糖尿病肾病中的变化 被引量:19

Changes of urinary exosomal leucine aminopeptidase and dipeptidyl peptidase 4 in diabetic nephropathy
下载PDF
导出
摘要 目的:探讨2型糖尿病患者尿液胞外体的亮氨酸氨基肽酶(exosome-LAP)及二肽基肽酶4(exosome-DPP4)的水平变化在糖尿病肾病发展过程中的意义。方法:选取127例2型糖尿病患者,根据24h尿白蛋白肌酐比(UACR)分为糖尿病正常白蛋白尿组(DM,43例)、微量白蛋白尿组(DN1,50例)和大量白蛋白尿组(DN2,34例)。另选健康对照组34例。采用特异性的单克隆抗体提纯胞外体,酶联免疫吸附法(ELISA)检测尿液胞外体的exosome-LAP和exosome-DPP4。同时检测糖化血江蛋白(HbA1c)、血胆固醇(CH)、肌酐(CR)、尿素氮(BUN)。应用多元逐步回归方法分析DPP4及LAP与HbA1c、CH、UACR、CR、BUN相关性。结果:DM、DN1、DN2组exosome-LAP和exosome-DPP4水平均显著高于正常组(均P<0.01);与DM组比较,DN2组exosome-LAP水平显著升高(P<0.01)。尿exosome-LAP、exosome-DPP4与HbA1c、CH、UACR、CR、BUN显著相关。逐步多元回归分析显示,CH、UACR是exosome-LAP的独立危险因素(均P<0.01);UACR、HbA1c是exosome-DPP4的独立危险因素(均P<0.01)。结论:Exosome-LAP和exosome-DPP4水平与糖尿病肾病严重程度密切相关,以上指标对于糖尿病肾病的诊断及预后估计具有一定临床价值。 AIM:To investigate the changes of urinary exosomal enzymes and the correlation with diabetic nephropathy. METHODS:Thirty-four healthy volunteers and 127 patients of type 2 diabetes mellitus(T2DM)were included in the study.The healthy volunteers served as control.The patients with T2DM were divided into 3 groups based on their 24 h urinary albumin/creatinine ratio(UACR):50 patients with microalbuminuria in early DN group(DN1),34 patients with macroalbuminuria in overt DN group(DN2)and 43 patients without albuminuria in DM group.The levels of urine exosomal leucine aminopeptidase(exosome-LAP)and exosomal dipeptidyl peptidase 4(exosome-DPP4)were determined by enzyme-linked immunosorbent assay(ELISA).The following methods were used to determine the biochemical parameters;liquid chromatography for glycated hemoglobin(HbA1c),chemical modification method for cholesterol (CH),Jaffe-kinetic assay for creatinine(CR)and urease-GLDH method for blood urea nitrogen(BUN).Multiple stepwise linear regressions were used to analyze the relationship of exosome-LAP or exosome-DPP4 with HbA1c,CH, UACR,CR and BUN.RESULTS:The levels of exosome-LAP and exosome-DPP4 in DM,DN1 and DN2 groups were significantly higher than those in control group(P〈0.01).The exosome-LAP in DN2 group was significantly higher than that in DM group.Correlation analysis showed that the levels of urinary exosome-LAP and exosome-DPP4 were positively correlated with HbA1c,CH,UACR,CR and BUN.Multiple stepwise linear regression analysis showed that CH and UACR were independent determinants for exosome-LAP(P〈0.01),and UACR and HbA1c were independent determinants for exosome-DPP4(P〈0.01).CONCLUSION:Urine exosome-LAP and exosome-DPP4 are correlated with the severity of diabetic nephropathy.These parameters may serve as clinical markers for the diagnosis and prognosis evaluation of diabetic nephropathy.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2011年第4期775-778,共4页 Chinese Journal of Pathophysiology
基金 山东省自然科学基金资助项目(No.ZR2009CM061)
关键词 糖尿病肾病 白蛋白尿 尿胞外体 亮氨酸氨肽酶 二肽基肽酶4 Diabetic nephropathies Albuminuria Urinary exosomes Leucine aminopeptidase Dipeptidyl peptidase 4
  • 相关文献

参考文献13

  • 1Mainous AG 3rd,Baker R,Koopman RJ,et al..Impact of the population at risk of diabetes on projections of diabetes burden in the United States:an epidemic on the way[J].Diabetologia,2007,50(5):934-940. 被引量:1
  • 2Simpson RJ,Jensen SS,Lim JW.Proteomic profiling of exosomes:current perspectives[J].Proteomics,2008,8(19):4083-4099. 被引量:1
  • 3Zhou H,Yuen PS,Pisitkun T,et al.Collection,storage,preservation,and normalization of human urinary exosomes for biomarker discovery[J].Kidney Int,2006,69(8):1471-1476. 被引量:1
  • 4Gonzales P,Pisitkun T,Knepper MA.Urinary exosomes:is there a future?[J].Nephrol Dial Transplant,2008,23(6):1799-1801. 被引量:1
  • 5Pisitkun T,Shen RF,Knepper MA.Identification and proteomic profiling of exosomes in human urine[J].Proc Natl Acad Sci USA,2004,101(36):13368-13373. 被引量:1
  • 6Deng JT,Hoylaerts MF,Nouwen EJ,et al.Purification of circulating liver plasma membrane fragments using a monoclonal antileucine aminopeptidase antibody[J].Hepatology,1996,23(3):445-454. 被引量:1
  • 7Chen WT,Kelly T.Seprase complexes in cellular invasiveness[J].Cancer Metastasis Rev,2003,22(2-3):259-269. 被引量:1
  • 8Lambeir AM,Durinx C,Scharpe S,et al.Dipeptidyl-peptidase IV from bench to bedside:an update on structuarl properties,functions,and clinical aspects of the enzyme DPP IV[J].Cirt Rev Clin Lab Sci,2003,40(3):209-294. 被引量:1
  • 9Mentlein R,Gallwitz B,Schmidt WE.Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide,glucagon-like peptide-1(7-36)amide,peptide histidine methionine and is responsible for their degradation in human serum[J].Eur J Biochem,1993,214(3):829-835. 被引量:1
  • 10Deacon CF,Johnsen AH,Holst JJ.Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo[J].J Clin Endocrinol Metab,1995,80(3):952-957. 被引量:1

二级参考文献7

  • 1lwaki-Egawa S, Watanabe Y, Kikuya Y, et al. Dipeptidyl peptidase IV from human purification,characterization, and N-terminal amino acid sequence. J Biochem, 1998, 124: 428-433. 被引量:1
  • 2Drucker DJ. Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action. Diabetes Care, 2007, 30: 1335-1343. 被引量:1
  • 3Deacon CF, Hughes TE, ttolst JJ. Dipeptidy/ peptidase IV inhibition potentiates the insulinotropic effect of glucagonlike peptide 1 in the anesthetized pig. Diabetes, 1998 47: 764-769. 被引量:1
  • 4Herman GA, Stein PP, ThornberTy NA, et al. Dipeptidyl peptidase-4 inhibitors for tile treatment of type 2 diabetes: focus on sitagliptin. Clin Pharmacol Ther, 2007, 81: 761- 767. 被引量:1
  • 5Ryskjaer J, Deacon CF, Carr RD, et al. Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endoe, rinol, 2006, 155: 485 -493. 被引量:1
  • 6陈灏珠 主编.实用内科学 第11版[M].北京:人民卫生出版社,2001.1652. 被引量:90
  • 7丁鹤林,傅祖植,等.糖尿病肾病发病机制及防治[J].中华内科杂志,2002,41(10):713-715. 被引量:56

共引文献3

同被引文献188

引证文献19

二级引证文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部